- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2012
- Public Summary Document (PSD) July 2012 PBAC Meeting - PDF
Saxagliptin – July 2012
Saxagliptin, tablet, 5 mg (as hydrochloride), Onglyza®
Last updated
8 November 2023